Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
Posted inAcademic and Scientific Journals Alzheimer's Disease Cassava Sciences Inc City University of New York Clinical Trials Dementia Drugs (Pharmaceuticals) Falsification of Data Food and Drug Administration Regulation and Deregulation of Industry Securities and Commodities Violations Securities and Exchange Commission United States Wang, Hoau-Yan your-feed-science

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds
Posted inAlzheimer's Disease Blood Brain Clinical Trials Computerized Axial Tomography (CAT Scans) Dementia Doctors JAMA (Journal of American Medical Assn) Memory Research Tests (Medical) your-feed-healthcare your-feed-science

A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds

It was much more accurate than primary care doctors using cognitive tests and CT scans. The findings could speed the quest for an affordable and accessible way to diagnose patients with memory problems.
New Drug Approved for Early Alzheimer’s
Posted inAlzheimer's Disease Biogen Inc Brain Clinical Trials Dementia Drugs (Pharmaceuticals) Eisai Co Ltd Eli Lilly and Company Food and Drug Administration Leqembi (Drug) Memory Placebos Prices (Fares, Fees and Rates) your-feed-healthcare your-feed-science

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.